We are very happy to welcome and announce our new R&D Engineer, Finn Beldring. Finn is a mechanical engineer, who has previously worked with industrial product development. His experience and knowledge are the reason behind hiring him. We are looking forward for his contribution and for a long and beneficial collaboration.
We are very happy to welcome our new R&D Engineer. Hossein Tarokh is a mechanical engineer who has also previously worked with developing medical devices. Hossein is hired by Dripmate A/S to help with the development of Dripmate’s products. We expect that Hossein will contribute with experience and knowledge and we look forward to a long and beneficial collaboration.
Today, Dripmate A/S has received its ISO 13485:2016 certificate.
CEO, Carsten Berger, comments:
“I am very pleased that Bureau Veritas certifies that the Management System of Dripmate A/S has been audited and found to be in accordance with the requirements of the management system standard ISO 13485:2016.”
Dripmate A/S has entered into an agreement with ALPHA Elektronik A/S in Næstved for the control of all components, the assembly of Dripmate’s product and the shipment of the final products directly to Dripmate’s customers.
In connection with this collaboration, Dripmate A/S has trained ALPHA’s employees in the handling of the Dripmate product.
Dripmate will as formerly be responsible for the release of products prior to shipment to customers.
CTO, Marie-Louise Rasmussen, comments: “We are very happy for the new collaboration. At our audit at ALPHA we got to experience ALPHA’s structured, well-educated and engaged employees. It was very reassuring to see how competent and well-organized ALPHA is. Furthermore, ALPHA is ISO 9001:2015 and ISO 13485:2016 certified and has previously produced medical device. We are sure that our products will be in good hands at ALPHA Elektronik.”
Macopharma, the distributor of Dripmate in France, Belgium, UK, Austria and French speaking export markets will in 2018 bring Dripmate to the following congresses:
– March 16th-17th Berlin Melia Hotel VZA. www.vza-info.de
– March 21st-23rd the 23rd Congress of the EAHP in Gothenburg, Sweden. www.eahp.eu/congresses
– May 3rd-5th, ADKA in Stuttgart, German hospital pharmacy congress, https://goo.gl/2mC7cz
– May 16th-18th, Hopipharm in Bordeaux, France.
– April 5th-6th VZA in Berlin, Germany.
– June 15th-16th in Dresden Germany. www.nzw.de/nzw_dresden.php
– June 22nd-23rd in Düsseldorf, Germany, Oncology Regional Congress. https://goo.gl/P1HP2Y
– October 3rd-5th, GERPAC in Presqu’île de Giens – Hyères, France
– October 16th-18th, Euro Pharmat in Nancy, France
Representatives from Dripmate A/S will be attending the EAPH congress in Gothenburg, Sweden, March 21st-23rd.
Dripmate A/S has in the beginning of February 2018 entered a collaboration with Bram Rosendahl Stampe Christiansen and Stefan Blaabjerg Høgild, who are studying for their MSc degrees in Design and Innovation from DTU (The Technical University of Denmark). Bram and Stefan will with Tobias Eifler (Assistant Professor at DTU) as their supervisor start a project with focus on optimizing Dripmate for production.
CTO, Marie-Louise Rasmussen comments: We look very much forward to the cooperation and are very excited to see what it will lead to. We believe it will be a great experience for Bram and Stefan as students and for Dripmate as a small company on a big market in constant development.
On December 27th 2017, the extraordinary general meeting decided for a capital increase in Dripmate A/S of 327.500 DKK (app. 44 TEUR) – the amount has subsequently been paid from the capital owner, as well as registered in the Danish Business Authority.
The company is thus still self-financed and therefore still has no need for bank or other forms of foreign funding.
On 31st of December 2016, the company had an equity of 8.7 MDKK (app 1.2 MEUR), which is in 2017 increase with 2.3 MDKK (app. 313 TEUR).
Two weeks ago, CEO, Carsten Berger and CTO, Marie-Louise Rasmussen visited Macopharma, who in August launched Dripmate to the French market. Since the launch, Macopharma has collaborated with the hospital of Valenciennes who received the first delivery.
CTO, Marie-Louise comments: “The meeting with Macopharma and the hospital has provided us with some great feedback that recognized the high quality, precision and ease of use of Dripmate. Furthermore, it has given us valuable insight including some good suggestions to further development which the doctors and nurses had thought of during the initial use. This feedback is highly appreciated as we are constantly working on improving Dripmate to live up to our customers’ needs and expectations. This meeting has contributed with significant inputs that will enable us to further improve our product”.
On october 18th 2017, a capital increase in Dripmate A/S of 900 TDKK (app. 121 TEUR) was agreed upon at an extraordinary general meeting. The amount has subsequently been paid from the capital owners, as well as registered in the Danish Business Authority. Dripmate A/S therefore continues as a self-financed company and thus, has no need for further bank loans or other forms of foreign funding. On 31st of December, Dripmate A/S had an equity of 8.7 MDKK (app 1.2 MEUR), which is in 2017 an increase of 2.0 MDKK (app. 269 TEUR). The company expects positive results for 2017.
Dripmate A/S has received an AA credit rating from Dun & Bradstreet Denmark.
CEO, Carsten Berger, comments: “I am proud that we, at this early stage, where we have just completed an extensive development phase, have achieved an AA credit rating even before our initial accounts, after our transition to sales and production, have been presented.”